COLUMBUS, Ohio, Sept. 4 /PRNewswire/ -- The Ohio State University Medical Center has invited experts from across the country to discuss translating scientific breakthroughs in the laboratory to clinical health care practice during the national Personalized Health Care Conference on Oct. 16-17.
Health care leaders, government policy makers, health care providers, researchers, industry experts, academic leaders, and consumer and patient advocacy groups will be among the more than 200 attendees gathering at Ohio State University's Biomedical Research Tower to hear from national leaders in personalized health care. Industry leaders will discuss breakthroughs in gene- based information that helps individuals prevent disease, tailor therapies and maintain health.
With a conference theme of "Translating Science to Personalized Health
Care," invited speakers include Linda Avey, co-founder and co-president,
23andMe, Inc.; Geoffrey Ginsberg, director, Center of Geonomic Medicine,
Duke Institute for Genome Sciences & Policy, Duke University; Lawrence
Lesko, director, Office of Clinical Pharmocology, Center for Drug
Evaluation and Research, U.S. Food and Drug Administration; Edison Liu,
executive director, Genome Institutes of Singapore, professor of medicine,
National University of Singapore, executive director, Singapore Cancer
Syndicate and executive director, Singapore Tissue Network; and Jeffrey
Trent, president and scientific director, Translational Genomics Research
Speakers and expert panels will discuss:
-- Opportunities and challenges of developing targeted therapies, genetic
tests, biomarkers and other diagnostic tools to deliver personalized
-- Strategies for increased collaboration between industry and academia
-- The latest developments in cancer biomarkers discoveries and the
current practice in personalized cancer therapy
-- Challenges and opportunities of
|SOURCE The Ohio State University Medical Center|
Copyright©2008 PR Newswire.
All rights reserved